Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

CUSIP: 03209R103

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / Common Stock
Shares outstanding
46,377,939
Total 13F shares
32,080,880
Share change
-1,420,606
Total reported value
$628,812,947
Price per share
$19.59
Number of holders
211
Value change
-$38,909,010
Number of buys
88
Number of sells
137

Security key

03209R103

Report period

Q1 2026

Institutions

211

Top holders

10

Top shareholders of AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Jack Y. Zhang
13D/G 3/4/5
CEO & CHIEF SCIENTIFIC OFFICER, Director, 10%+ Owner
25%
12,524,153
$301,456,363 $0 31 Dec 2024
BlackRock, Inc.
13F 13D/G
Company
12%
from 13D/G
5,462,015
$146,272,762 31 Dec 2025
VANGUARD GROUP INC
13F
Company
5.6%
2,608,158
$69,846,471 31 Dec 2025
13F
Mary Z. Luo
3/4/5
COO,Chief Scientist & Chairman, Director, 10%+ Owner
class O/S missing
1,109,416
$63,239,930 10 Jan 2024
TD ASSET MANAGEMENT INC
13F
Company
4.2%
1,963,052
$52,570,533 31 Dec 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
3.9%
1,799,685
$48,196,126 31 Dec 2025
13F
STATE STREET CORP
13F
Company
3.3%
1,531,786
$41,021,229 31 Dec 2025
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
3%
1,394,463
$37,343,725 31 Dec 2025
13F
MARSHALL WACE, LLP
13F
Company
2.7%
1,237,284
$33,134,466 31 Dec 2025
13F
Epoch Investment Partners, Inc.
13F
Company
2.4%
1,126,585
$30,169,946 31 Dec 2025
13F
Boston Trust Walden Corp
13F
Company
2.3%
1,087,266
$29,116,984 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.9%
886,825
$23,753,330 31 Dec 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
1.4%
665,336
$17,817,698 31 Dec 2025
13F
MORGAN STANLEY
13F
Company
1.3%
591,631
$15,843,918 31 Dec 2025
13F
Richard Koo
3/4/5
Director
mixed-class rows
286,471
mixed-class rows
$15,350,254 07 Jun 2021
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
1.2%
559,426
$14,981,428 31 Dec 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
1.2%
557,066
$14,918,227 31 Dec 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.2%
556,709
$14,908,667 31 Dec 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.2%
544,700
$14,587,066 31 Dec 2025
13F
Invesco Ltd.
13F
Company
1.1%
501,404
$13,427,600 31 Dec 2025
13F
SYSTEMATIC FINANCIAL MANAGEMENT LP
13F
Company
0.94%
435,580
$11,664,862 31 Dec 2025
13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
13F
Company
0.87%
402,563
$10,780,637 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
0.8%
371,391
$9,945,851 31 Dec 2025
13F
ROYCE & ASSOCIATES LP
13F
Company
0.76%
352,297
$9,434,514 31 Dec 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.76%
350,707
$9,391,937 31 Dec 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.7%
323,549
$8,664,642 31 Dec 2025
13F
Clark Capital Management Group, Inc.
13F
Company
0.68%
317,482
$8,502,168 31 Dec 2025
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.66%
305,161
$8,172,211 31 Dec 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.63%
290,673
$7,784,223 31 Dec 2025
13F
Bank of New York Mellon Corp
13F
Company
0.56%
259,061
$6,937,655 31 Dec 2025
13F
UBS Group AG
13F
Company
0.55%
256,624
$6,872,391 31 Dec 2025
13F
Bridge City Capital, LLC
13F
Company
0.51%
235,485
$6,306,288 31 Dec 2025
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.5%
231,305
$6,194,348 31 Dec 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.49%
228,724
$6,125,229 31 Dec 2025
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.47%
217,974
$5,837,344 31 Dec 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.47%
217,537
$5,825,641 31 Dec 2025
13F
DENALI ADVISORS LLC
13F
Company
0.46%
211,765
$5,671,067 31 Dec 2025
13F
Pacer Advisors, Inc.
13F
Company
0.38%
177,744
$4,759,984 31 Dec 2025
13F
Rong Zhou
3/4/5
SENIOR EVP, PRODUCTION CENTER
mixed-class rows
257,895
mixed-class rows
$4,676,915 -$256,379 15 Mar 2026
William J. Peters
3/4/5
CFO, EVP & TREASURER, Director
mixed-class rows
296,134
mixed-class rows
$4,637,418 15 Mar 2026
Empowered Funds, LLC
13F
Company
0.36%
165,907
$4,442,989 31 Dec 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.34%
158,644
$4,248,486 31 Dec 2025
13F
Howard Lee
3/4/5
Director
mixed-class rows
163,378
mixed-class rows
$3,952,895 02 Jun 2025
FIRST TRUST ADVISORS LP
13F
Company
0.3%
140,310
$3,757,501 31 Dec 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.29%
133,715
$3,580,888 31 Dec 2025
13F
LAM GROUP, INC.
13F
Company
0.28%
130,800
$3,502,824 31 Dec 2025
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.28%
129,144
$3,459,768 31 Dec 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.28%
128,174
$3,432,501 31 Dec 2025
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.27%
125,968
$3,373,423 31 Dec 2025
13F
ALGERT GLOBAL LLC
13F
Company
0.27%
125,130
$3,351,000 31 Dec 2025
13F

Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2026

As of 31 Mar 2026, Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by 211 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,080,880 shares. The largest 10 holders included BlackRock, Inc., DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC, TD Asset Management Inc, FULLER & THALER ASSET MANAGEMENT, INC., MARSHALL WACE, LLP, AMERICAN CENTURY COMPANIES INC, GEODE CAPITAL MANAGEMENT, LLC, and Boston Trust Walden Corp. This page lists 211 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
232
Q1 2026 holders
211
Holder diff
-21
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .